Back to BlackRock, Inc. BlackRock, Inc.

KYMRKYMR
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in KYMERA THERAPEUTICS INC

BlackRock, Inc. holds 5.5M shares of KYMR (KYMERA THERAPEUTICS INC), worth $635.1M as of 2026-Q2. The position was increased (+9.4% shares). KYMR represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$635.1M

Current Shares

5.5M

Total Value Change

+$459.8M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.5M
+9.4%
$635.1M0.0%$114.67
35
2026-Q1
Increased
5.1M
+1.1%
$421.5M0.0%$86.35
31
2025-Q4
Increased
5M
+14.6%
$389.4M0.0%$78.12
36
2025-Q3
Increased
4.4M
+5.2%
$247.1M0.0%$58.50
32
2025-Q2
Decreased
4.1M
-3.1%
$181M0.0%$44.12
0
2025-Q1
Decreased
4.3M
-1.7%
$117.2M0.0%$29.62
0
2024-Q4
New
4.4M
-
$175.3M0.0%$39.32
42

Other major holders of KYMR: FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used